|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Physiology, University of Munich, Munich, Germany
2 Biochemistry, Max-Plank-Institute, Martinsried, Germany
3 Medical Elecrtonics, Technical University, Munich, Germany
4 Clinical Chemistry and Clinical Biochemistry, University of Munich, Munich, Germany
* To whom correspondence should be addressed. E-mail: B.F.Becker{at}lrz.uni-muenchen.de.
The intracellular protease calpain, abundant in endothelial cells (EC), is assumed to be inactive under physiological conditions but may account for Ca++-linked pathophysiological events. However, non-stimulated EC contained autolysed, activated calpain. Adding 12-48µM calpain inhibitor I (CI) or 0.5-1µM of the novel, membrane permeable conjugate of calpastatin peptide-penetratin (CPP) caused rapid rounding and retraction of cultured EC (phase contrast, capacitance), and translocation of Syk, Rac and Rho to the membrane, signifying activation upon inhibition of calpain. Isolated hearts (guinea pig) perfused with 12 µM CI or 0.5 µM CPP developed coronary leak. We conclude that calpain is constitutively active in EC and regulates vascular permeability by governing cell-cell attachment.
This article has been cited by other articles:
![]() |
R. Scalia, Y. Gong, B. Berzins, L. J. Zhao, and K. Sharma Hyperglycemia Is a Major Determinant of Albumin Permeability in Diabetic Microcirculation: The Role of {micro}-Calpain Diabetes, July 1, 2007; 56(7): 1842 - 1849. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |